News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
19,228 Results
Type
Article (1539)
Company Profile (6)
Press Release (17683)
Section
Business (4694)
Career Advice (11)
Deals (821)
Drug Delivery (3)
Drug Development (2697)
Employer Resources (4)
FDA (909)
Job Trends (499)
News (8900)
Policy (818)
Tag
Academia (112)
Alliances (1024)
ALS (26)
Alzheimer's disease (120)
Approvals (906)
Artificial intelligence (4)
Bankruptcy (8)
Best Places to Work (440)
Biosimilars (2)
Biotechnology (7)
Brain cancer (1)
Breast cancer (4)
Cancer (29)
Cardiovascular disease (4)
Career advice (11)
CAR-T (3)
Cell therapy (16)
Clinical research (2034)
Collaboration (19)
Compensation (16)
COVID-19 (66)
CRISPR (1)
C-suite (5)
Data (70)
Depression (2)
Diabetes (2)
Diagnostics (91)
Drug discovery (5)
Drug pricing (3)
Duchenne muscular dystrophy (6)
Earnings (1910)
Editorial (2)
Employer branding (2)
Employer resources (4)
Events (2453)
Executive appointments (19)
FDA (956)
Frontotemporal dementia (1)
Funding (22)
Gene editing (3)
Gene therapy (23)
GLP-1 (20)
Government (115)
Guidances (7)
Healthcare (555)
Huntington's disease (4)
IgA nephropathy (1)
Immunology and inflammation (5)
Indications (1)
Infectious disease (68)
Inflammatory bowel disease (2)
Influenza (1)
Interviews (1)
IPO (365)
Job creations (65)
Job search strategy (10)
Layoffs (17)
Legal (149)
Liver cancer (2)
Lung cancer (3)
Lymphoma (2)
Management (1)
Manufacturing (6)
MASH (1)
Medical device (1141)
Medtech (1142)
Mergers & acquisitions (475)
Metabolic disorders (7)
Multiple sclerosis (16)
Neurodegenerative disease (12)
Neuropsychiatric disorders (1)
Neuroscience (190)
NextGen: Class of 2025 (226)
Non-profit (163)
Obesity (5)
Opinion (12)
Pain (10)
Parkinson's disease (10)
Partnered (1)
Patents (3)
Patient recruitment (2)
People (1405)
Pharmaceutical (1)
Phase I (709)
Phase II (979)
Phase III (677)
Pipeline (40)
Policy (4)
Postmarket research (99)
Preclinical (292)
Prostate cancer (1)
Radiopharmaceuticals (3)
Rare diseases (19)
Real estate (127)
Recruiting (2)
Regulatory (615)
Reports (3)
Research institute (100)
Schizophrenia (2)
Series A (6)
Series B (4)
Sickle cell disease (1)
Special edition (1)
Spinal muscular atrophy (166)
Sponsored (1)
Startups (127)
Tariffs (1)
The Weekly (2)
Vaccines (13)
Venture capitalists (2)
Weight loss (2)
Date
Last 7 days (19)
Last 30 days (64)
Last 365 days (902)
2025 (319)
2024 (1022)
2023 (1149)
2022 (1833)
2021 (1837)
2020 (1559)
2019 (1369)
2018 (1084)
2017 (1099)
2016 (1074)
2015 (1134)
2014 (793)
2013 (699)
2012 (673)
2011 (626)
2010 (531)
Location
Africa (8)
Alabama (1)
Arizona (2)
Asia (761)
Australia (153)
California (169)
Canada (64)
China (5)
Colorado (5)
Connecticut (11)
Europe (1997)
Florida (18)
Georgia (2)
Idaho (2)
Illinois (14)
Indiana (4)
Iowa (1)
Japan (2)
Kansas (1)
Louisiana (2)
Maryland (13)
Massachusetts (134)
Michigan (7)
Minnesota (21)
Mississippi (1)
Missouri (1)
Montana (11)
New Jersey (37)
New Mexico (1)
New York (19)
North Carolina (9)
Northern California (64)
Ohio (6)
Oregon (2)
Pennsylvania (30)
South America (19)
Southern California (70)
Tennessee (1)
Texas (55)
United States (580)
Utah (4)
Virginia (4)
Washington State (2)
19,228 Results for "spinal singularity".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Spinal muscular atrophy
6 Therapies on the Horizon for Spinal Muscular Atrophy
Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several companies—including Novartis, Scholar Rock and Biogen—progressing novel candidates through clinical trials.
March 24, 2025
·
5 min read
·
Natalia Mesa
Approvals
Roche’s Evrysdi Becomes First Pill Cleared for Spinal Muscular Atrophy
Evrysdi is the first, and so far only, noninvasive disease-modifying treatment for spinal muscular atrophy.
February 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Singular Genomics Announces Closing of Acquisition by Deerfield Management
February 24, 2025
·
4 min read
Neurodegenerative disease
Scholar Rock’s Shares Soar 300% After Phase III Win in Spinal Muscular Atrophy
With Monday’s data from SAPPHIRE, Scholar Rock is building toward regulatory submissions for apitegromab in spinal muscular atrophy in the first quarter of 2025.
October 8, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 3rd Annual Spinal Cord Injury Investor Symposium
April 22, 2025
·
8 min read
Press Releases
Study Confirms Significant Clinical Benefit of Neo Medical’s Force Control Technology™ in Spinal Fusion Surgery
April 1, 2025
·
4 min read
Press Releases
Cellino and Matricelf Announce Global Collaboration to Scale Personalized Spinal Cord Injury Treatments
March 11, 2025
·
3 min read
Press Releases
Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury
February 12, 2025
·
11 min read
Biotech Beach
Singular Genomics Announces 1-for-30 Reverse Stock Split
Singular Genomics Systems, Inc. announced that on June 26, 2024, effective at 12:01 a.m. Eastern Time, it will effectuate a 1-for-30 reverse split of its common stock.
June 21, 2024
·
5 min read
Press Releases
FDA Approves New Tablet Form of Evrysdi for Treatment of Spinal Muscular Atrophy
February 13, 2025
·
4 min read
1 of 1,923
Next
